Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01794403 · ClinicalTrials.gov registry record · NA
Radiation Hypofractionation Via Extended Versus Accelerated Therapy (HEAT) For Prostate Cancer
A NA study of Prostate Cancer, sponsored by University of Miami.
- Active
- Registry status
- NA
- Development phase
- 161
- Enrollment target
- 3
- Study locations
NCT01794403: Active NA study of Prostate Cancer, sponsored by University of Miami.
NCT01794403 is a NA study of Prostate Cancer that is active but no longer recruiting, run by University of Miami. The registered enrollment target is 161 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (74% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01794403, a NA study of Prostate Cancer, is active but no longer recruiting, sponsored by University of Miami.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 161 participants
- Enrollment target
- 3
- Study locations
Study Summary
Accelerated Hypofractionation Radiotherapy for prostate cancer of 36.25 Gy delivered in 5 fractions will not be inferior to the standard treatment of 70.2 Gy given in 26 fractions with respect to four-year biochemical failure (PSA failure) by Phoenix definition post-treatment completion.
Primary Outcome
The number of participants achieving four-year biochemical failure between both treatment arms will be reported. Biochemical Failure will be evaluated using the Phoenix definition wherein failure occurs when the Prostate Specific Antigen (PSA) is ≥ 2 ng/ml more than the lowest PSA measurement before the current one.
Conditions Studied
Interventions
- RADIATION Extended Hypofractionation Radiotherapy
- RADIATION Accelerated Hypofractionation Radiotherapy
Study Locations (3)
Florida
- University of Miami - Miami
New South Wales
- Northern Sydney Local Health District - Royal North Shore Hospital - St Leonards
Turin
- A.O.U. Città della Salute e della Scienza di Torino - University Hospital Trust of Turin - Turin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 161 participants |
| Start Date | 2013-04-04 |
| Est. Completion | 2027-02-01 |
| Phase | NA |
What the registry record for NCT01794403 still lists
NCT01794403 is an interventional study that assigns participants to a tested intervention. The registered 161 participants enrollment target is mid-sized for trials with a published cap, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (74% lower).
The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which Extended Hypofractionation Radiotherapy is the first listed.
NCT01794403 reports a single indexed study location in Florida, New South Wales, Turin.
Frequently Asked Questions
What is clinical trial NCT01794403 about?
NCT01794403 is a clinical study titled "Radiation Hypofractionation Via Extended Versus Accelerated Therapy (HEAT) For Prostate Cancer". Accelerated Hypofractionation Radiotherapy for prostate cancer of 36.25 Gy delivered in 5 fractions will not be inferior to the standard treatment of 70.2 Gy given in 26 fractions with respect to four-year biochemical failure (PSA failure) by Phoenix definition post-treatment completion.
What is the current status of trial NCT01794403?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 161 participants. The study started on 2013-04-04. Estimated completion is 2027-02-01.
What conditions does trial NCT01794403 study?
This clinical trial studies the following conditions: Prostate Cancer.
What interventions are being tested in trial NCT01794403?
The interventions under investigation include: Extended Hypofractionation Radiotherapy (RADIATION), Accelerated Hypofractionation Radiotherapy (RADIATION).
Who is sponsoring clinical trial NCT01794403?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01794403 being conducted?
This trial has 3 study locations across Florida, New South Wales, Turin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01794403's enrollment target sits among peer trials
161 253rd of 735 higher than 481 of 735 other Prostate Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Prostate Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
RECRUITING · NA
-
Diffusion Basis Spectrum Imaging of the Prostate
RECRUITING · NA
-
Micro-UltraSound In Cancer - Active Surveillance
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
SBRT Boost for Unfavorable Prostate Cancer'
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06546670 · 161 participants · Phase 1
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
- NCT06616766 · 161 participants · Phase 1
A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate Safety, Tolerability, PK and Anti-tumor Activity of YH42946
- NCT06752356 · 161 participants · Phase 3
A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- NCT07144826 · 161 participants · Early Phase 1
Effects of a Probiotic Intervention on the Gut and Vaginal Microbiome in Patients With Advanced or Recurrent Ovarian Cancer Undergoing Treatment With Platinum Chemotherapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI